Lichen Gao

1.5k total citations · 2 hit papers
34 papers, 1.1k citations indexed

About

Lichen Gao is a scholar working on Pharmacology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lichen Gao has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lichen Gao's work include Ferroptosis and cancer prognosis (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Drug-Induced Adverse Reactions (3 papers). Lichen Gao is often cited by papers focused on Ferroptosis and cancer prognosis (5 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Drug-Induced Adverse Reactions (3 papers). Lichen Gao collaborates with scholars based in China and United States. Lichen Gao's co-authors include Hongyu Luo, Hui‐Zhi Long, Ziwei Zhou, Dan‐Dan Wen, Shuo‐Guo Xu, Feng‐Jiao Li, Yan Cheng, Ziwei Zhou, Yan Cheng and Lin Cheng and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and Journal of the Neurological Sciences.

In The Last Decade

Lichen Gao

31 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer’s Disease and Parkinson’s Disease

2021 321 citations Hui‐Zhi Long, Ziwei Zhou et al. Frontiers in Pharmacology profile →
System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy

2022 272 citations Feng‐Jiao Li, Hui‐Zhi Long et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lichen Gao China	15	499	267	247	146	117	34	1.1k
Honghai Wu China	22	700 1.4×	131 0.5×	192 0.8×	105 0.7×	101 0.9×	64	1.6k
Shaowu Cheng China	19	412 0.8×	124 0.5×	137 0.6×	187 1.3×	71 0.6×	41	901
Feng Guo China	23	725 1.5×	233 0.9×	133 0.5×	144 1.0×	121 1.0×	87	1.7k
Zhi Dong China	18	409 0.8×	246 0.9×	161 0.7×	77 0.5×	196 1.7×	55	1.2k
Dongyu Min China	16	395 0.8×	122 0.5×	138 0.6×	109 0.7×	124 1.1×	40	854
Qidi Ai China	24	795 1.6×	171 0.6×	158 0.6×	125 0.9×	97 0.8×	59	1.6k
Zhenlong Xin China	20	739 1.5×	90 0.3×	164 0.7×	214 1.5×	71 0.6×	27	1.5k
Dheyauldeen Shabeeb Iran	25	644 1.3×	322 1.2×	162 0.7×	164 1.1×	132 1.1×	51	1.7k
Xiaofang Fan China	21	536 1.1×	167 0.6×	245 1.0×	163 1.1×	253 2.2×	91	1.4k

Countries citing papers authored by Lichen Gao

Since Specialization

Citations

This map shows the geographic impact of Lichen Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lichen Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lichen Gao more than expected).

Fields of papers citing papers by Lichen Gao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lichen Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lichen Gao. The network helps show where Lichen Gao may publish in the future.

Co-authorship network of co-authors of Lichen Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Lichen Gao. A scholar is included among the top collaborators of Lichen Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lichen Gao. Lichen Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gao, Lichen, et al.. (2025). Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and the risk of early-onset post-stroke depression: a prospective study. Frontiers in Neurology. 16. 1645765–1645765.

Yuan, Mengqin, et al.. (2025). Isoliensinine confers neuroprotection and alleviates LPS-induced neuroinflammation in microglia by regulating the MAPK/NF-κB signaling. Frontiers in Pharmacology. 16. 1675865–1675865.

Long, Hui‐Zhi, et al.. (2024). Isoliensinine activated the Nrf2/GPX4 pathway to inhibit glutamate‐induced ferroptosis in HT‐22 cells. Journal of Biochemical and Molecular Toxicology. 38(9). e23794–e23794. 6 indexed citations

Yuan, Mengqin, et al.. (2024). Isoliensinine suppressed gastric cancer cell proliferation and migration by targeting TGFBR1 to regulate TGF-β-smad signaling pathways. Frontiers in Pharmacology. 15. 1438161–1438161. 3 indexed citations

Li, Feng‐Jiao, Hui‐Zhi Long, Ziwei Zhou, et al.. (2022). System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Frontiers in Pharmacology. 13. 910292–910292. 272 indexed citations breakdown →

Luo, Hongyu, Hui‐Zhi Long, Ziwei Zhou, et al.. (2022). Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions. Drugs in R&D. 22(4). 311–320. 3 indexed citations

Zhou, Ziwei, Hui‐Zhi Long, Shuo‐Guo Xu, et al.. (2022). Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways. Frontiers in Pharmacology. 13. 899208–899208. 20 indexed citations

Li, Feng‐Jiao, Hui‐Zhi Long, Ziwei Zhou, et al.. (2022). Relationship between miRNA and ferroptosis in tumors. Frontiers in Pharmacology. 13. 977062–977062. 34 indexed citations

Li, Chao, Chaopeng Li, Xiaohui Li, et al.. (2021). CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population. Frontiers in Pharmacology. 12. 730461–730461. 9 indexed citations

10.

Cheng, Yan, Hongli Li, Ziwei Zhou, et al.. (2021). Isoliensinine: A Natural Compound with “Drug-Like” Potential. Frontiers in Pharmacology. 12. 630385–630385. 35 indexed citations

11.

Zhou, Meiliang, et al.. (2019). Advances in extraction and mechanism of antitumor active components from Fagopyrum dibotrys. Zhongguo linchuang yaolixue yu zhiliaoxue. 24(7). 833. 1 indexed citations

12.

Zhang, Lihua, et al.. (2019). Causative drugs for drug-induced cutaneous reactions in central China: a 608-case analysis. Anais Brasileiros de Dermatologia. 94(6). 664–670. 12 indexed citations

13.

Wang, Di, Lichen Gao, Xueting Liu, Chuang Yuan, & Guihua Wang. (2017). Improved antitumor effect of ionizing radiation in combination with rapamycin for treating nasopharyngeal carcinoma. Oncology Letters. 14(1). 1105–1108. 10 indexed citations

14.

Yao, Shun, et al.. (2015). Thalamocortical Sensorimotor Circuit Damage Associated with Disorders of Consciousness for Diffuse Axonal Injury Patients. Journal of the Neurological Sciences. 356(1-2). 168–174. 27 indexed citations

15.

Cheng, Lin, Lihua Zhang, Lichen Gao, et al.. (2015). Genotyping HLA‐B*5801 for Allopurinol‐Induced Severe Cutaneous Adverse Reactions: An Accurate and Prompt Method. Clinical and Translational Science. 8(6). 834–836. 7 indexed citations

16.

Yan, Lirong, et al.. (2015). Dysfunctional putamen modulation during bimanual finger-to-thumb movement in patients with Parkinson's disease. Frontiers in Human Neuroscience. 9. 516–516. 14 indexed citations

17.

Gao, Lichen, et al.. (2014). Advances in pharmacogenomics research of adverse effects of hypertension therapy drugs. Zhongguo linchuang yaolixue yu zhiliaoxue. 1183–1188. 1 indexed citations

18.

Gao, Lichen, Zhengyu Huang, Hongguang Huang, et al.. (2014). Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients. European Journal of Clinical Pharmacology. 71(1). 43–50. 19 indexed citations

19.

Gao, Lichen, Yijing He, Jie Tang, et al.. (2013). Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate. PLoS ONE. 8(6). e62489–e62489. 15 indexed citations

20.

Zhang, Yingjin, Xi Huang, Yang Wang, et al.. (2011). Ferulic acid-induced anti-depression and prokinetics similar to Chaihu–Shugan–San via polypharmacology. Brain Research Bulletin. 86(3-4). 222–228. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact